My Genome Screen
PrivateLast Round
Accelerator
May 20, 2024
Total Funding Raised
$30,000
Company Overview
My Genome Screen is a decision/risk analysis company that operates a personalized health diagnostics service using AI and genomic data to provide diagnoses, health alerts, and lifestyle recommendations for genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Precision Medicine, Biotechnology
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
My Genome Screen Comparables
Compare My Genome Screen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Breakthrough Genomics | 82% | |
| enGenome | 81% | |
| Saphetor | 79% |
My Genome Screen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 20, 2024 |
Key People
Founding team and executive leadership
My Genome Screen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sabancı ARF | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2024
$30K raised from Sabancı ARF
My Genome Screen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about My Genome Screen's valuation, stock price, and market status.
Is My Genome Screen a public or private company?
My Genome Screen is a private company.
What is the current stock price of My Genome Screen?
My Genome Screen is a private company with no public stock price. No recent secondary market data is available.
How much is My Genome Screen worth (valuation)?
Valuation information for My Genome Screen is not publicly available.
Can I buy My Genome Screen stock?
My Genome Screen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was My Genome Screen's last funding round?
Funding round information for My Genome Screen is not publicly available.
Who are the main investors in My Genome Screen?
Investor information for My Genome Screen is not publicly disclosed.
Will My Genome Screen IPO soon?
No public IPO plans have been announced for My Genome Screen.
How can I track My Genome Screen secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor My Genome Screen's secondary market activity and sign up for updates.